Schedule 13D ownership disclosure

Aurinia Pharmaceuticals Inc

Security class unavailable · CUSIP: 05156V102

Event date: 2020-07-22

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,425,338
Percent of class
6.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-086013
Form type
SC 13D/A
Filer
Aurinia Pharmaceuticals Inc.
CIK
CIK 1600620
Filed
Jul 23, 2020
Reporting period
Jul 22, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub